AstraZeneca, IBM ink outsourcing deal

Pharmaceutical giant AstraZeneca PLC in London will outsource its IT operations to IBM Corp. in a deal worth US$1.7 billion over seven years, the companies announced this week. IBM's Global Services division will run AstraZeneca's global IT infrastructure, performing a range of IT functions in support of pharmaceutical divisions in 45 countries, according to IBM.

Join the newsletter!

Or

Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

More about AstraZenecaIBM Australia

Show Comments